Emperra's Bluetooth insulin pen and smartphone app in last CE approval stages - European Pharmaceutical Manufacturer
Por um escritor misterioso
Descrição
Emperra GmbH E-Health Technologies has announced that its integrated telemonitoring system — comprising of Bluetooth-enabled ESYSTA smart insulin pen and diabetes smartphone app — is almost ready for market launch.
Frontiers The Review of Insulin Pens—Past, Present, and Look to
Smart Insulin Pen Market Detailed In New Research Report 2022
Companion Medical Announces US Commercial Launch of Smart Insulin
The Internet of Things in assisted reproduction - ScienceDirect
Medical devices, smart drug delivery, wearables and technology for
Emerging Diabetes Technologies: Continuous Glucose Monitors
PDF) The Review of Insulin Pens—Past, Present, and Look to the Future
Medical devices, smart drug delivery, wearables and technology for
Meet the InPen System - Northern Texas and Oklahoma Chapter
de
por adulto (o preço varia de acordo com o tamanho do grupo)